ImmuType™ is a Celdara Medical Enterprise focused on providing improved care for patients with systemic autoimmune disease. By supporting patient stratification and identifying treatment responders based on each patient’s unique molecular profile, ImmuType™ can improve the success rate, while reducing time and cost of clinical trials. Beyond enrollment, ImmuType™ can […]
Celdara Medical, LLC today announced that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded a three-year Small Business Innovation Research (SBIR) Fast-Track award to fund the company’s advancement of CM-CX1, a chimeric antigen receptor (CAR) T cell therapy for the treatment of ovarian clear […]
Supported by Celdara Medical and named after its co-founder, the new building and STEM lab is designed for authentic, experiential learning and serves as an exemplary partnership for the future of STEM education LEBANON, N.H. – August 26, 2021 — Celdara Medical, LLC (Celdara), The New Hampshire Academy of Science […]
Celdara Medical, LLC (“Celdara”) announced today the addition of Antonito T. Panganiban, Ph.D., to the Pandemic Security Initiative’s Scientific Advisory Board (SAB), a group of outstanding scientists and infectious disease experts who will advise the Pandemic Security Initiative as it seeks to protect the nation from future pandemics. The SAB […]
BALTIMORE and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 /PRNewswire/ — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products for the patients who need them most, today announced a new strategic collaboration with the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence […]
CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ — Celdara Medical, LLC (“Celdara”) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic […]
Celdara Medical, LLC is pleased to announce the recent hiring of Lauren Brunswick, JD, who will join the Celdara team as General Counsel. Lauren will lead Celdara’s legal function, providing support for Celdara’s strategy, risk management, operations, and portfolio management processes. Lauren remarked, “I am thrilled to join the exceptionally […]
Celdara Medical, LLC today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded a two-year Small Business Innovation Research (SBIR) contract to fund the development of the novel, parasite-derived, antigen-sparing protein adjuvant ASP-1 for flu vaccines. This project builds […]
Celdara Medical, LLC today announced that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded a Phase I Small Business Innovation Research (SBIR) award to fund the company’s advancement of anti-hIAPP antibodies for the diagnosis of prediabetes and Type […]
The problem is painful and obvious: while epic sums are being spent, every day more people are dying, and we are all living with fewer freedoms. We would not choose to begin the design of our weapons after declaring war. Why did we choose to start developing life-saving medicines against infectious diseases […]